Early trip to the GP gives big boost to lung cancer patients

December 9, 2013
Early trip to the GP gives big boost to lung cancer patients

A powerful campaign urging people with a three week old cough to get checked out by their doctor has resulted in a dramatic rise in the number of lung cancers detected earlier according to an analysis of the results announced by Cancer Research UK today.

Experts say this will offer patients their best chance of life-saving surgery and longer survival for the biggest cancer killer.

The hard-hitting Be Clear On Cancer Campaign led to around 700 extra patients being diagnosed with lung cancer - many at an early stage – and resulted in around 300 more patients getting surgery which gives them the best chance of prolonged survival.

The Public Health England campaign which is supported by Cancer Research UK, NHS England and the Department of Health, ran throughout England from May-June 2012. People were urged to go to the GP if they had a cough lasting longer than three weeks.

As a result almost 10 per cent more people (around 700) were diagnosed with lung cancer than in the same months the previous year and around 400 more patients had their lung cancer picked up at an – the earlier cancer is detected the more likely treatment is to be successful. There was also a significant decrease in the proportion of people diagnosed at a late stage.

And best of all around 300 more of those diagnosed received surgery which is vital for better survival.

Dr Mick Peake, lung cancer expert and consultant in respiratory medicine at the University of Leicester, said: "We are starting to see a dramatic change in potentially curative treatments for lung cancer. As a result of the Be Clear on Cancer campaign we've seen as much progress, particularly in the proportion of patients having an operation for their lung cancer, in those three months as in the previous two years."

Dr Harpal Kumar, chief executive of Cancer Research UK, said: "It is great news that this campaign has raised awareness of lung cancer symptoms among those most at risk of the disease. By acting quickly if you notice a possible symptom, you can give yourself the best chance of survival. In many cases it won't be cancer, but it is better to be sure and, if it is cancer, to detect it earlier rather than later.

"Earlier diagnosis, combined with the pioneering research that brings better and kinder treatments to patients, means we are starting to make much needed headway against a type of cancer that has killed millions. This vital combination will help bring forward the day when no one dies prematurely from lung cancer."

Sean Duffy, National Clinical Director for Cancer at NHS England, said: "Until recently a lung cancer patient in Sweden was nearly 70 per cent more likely to survive their disease for at least five years than if they lived in England. So I am therefore delighted that this new set of figures shows that the Be Clear on Cancer campaign has helped speed up our progress in survival with hundreds of patients receiving potential life saving surgery as a result of this campaign"

Professor Kevin Fenton, Director of Health and Wellbeing at PHE, said: "To see such encouraging results from the first national Be Clear on Cancer lung campaign is very reassuring. It shows that we can make a difference when it comes to one of the biggest cancer killers. Public Health England is committed to helping prevent and diagnose cancers earlier. We are now looking to re-run the campaign in 2014 which we hope will improve survival for even more ."

Explore further: Lung cancer surgery survival rates unchanged since 1950s

Related Stories

Lung cancer surgery survival rates unchanged since 1950s

November 20, 2013
No treatment for lung cancer today gives us significantly better chances of survival than chest surgery from 60 years ago, according to a medical historian from The University of Manchester.

Experimental drugs for breast cancer could treat lung cancer too

August 13, 2013
Cancer Research UK -funded scientists have discovered that experimental drugs first developed for breast and ovarian cancer could be used to treat the most common type of lung cancer, reveals research published in Oncogene ...

New computer program to help GPs know when to send patients for cancer tests

November 5, 2013
New software that estimates the likelihood that someone has cancer based on their symptoms could help GPs decide which patients to send for further tests, according to a study announced at the National Cancer Research Institute ...

Researchers study survival in African American versus Caucasian lung cancer patients

September 4, 2013
According to the American Cancer Society, an estimated 160,340 lung cancer deaths occurred in the United States in 2012, accounting for 28 percent of all cancer deaths. While survival from lung cancer has improved since the ...

Nearly all men survive testicular cancer

July 29, 2013
Survival for testicular cancer has risen by almost 30 per cent in the last 40 years, with nearly all men now beating the disease, according to figures published by Cancer Research UK.

Minimal dose CT superior to chest X-ray for detection of recurrent lung cancer

May 6, 2013
Lung cancer is associated with very high mortality, in part because it is hard to detect at early stages, but also because it can recur frequently after surgical removal. The question arises as to what is the best way to ...

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.